INTRODUCTION: Foot amputation wounds in patients with diabetes are complex and treatment is often difficult. At the moment negative pressure wound therapy (NPWT) is widely used for the treatment of several types of wounds. Nevertheless, the clinical evidence to support the application of this dressing in foot amputation wounds in patients with diabetes is scarce. The aim of this study was to evaluate the efficacy of NPWT compared with standard wound dressing to treat diabetic foot amputation wounds. PATIENTS AND METHOD: Randomised controlled trial. Diabetic patients aged 18 years or older with a foot amputation wound were assigned to treatment with NPWT (A group) or standard wound dressing (B group). Primary efficacy end point was time in reaching 90% of wound granulation. A size of sample of 11 patients per group was used. NPWT was prepared with a polyurethane ether foam dressing, a Nelaton catheter, a transparent adhesive drape and continuous negative pressure of 100 mmHg. The wound was treated every 48-72 h and evaluated weekly. Descriptive and analytical statistics were used. RESULTS: There were 24 patients, with a mean age of 61.8 +/- 9 years (79% men), 12 in each group. The average time to reach 90% of granulation was lower in A group (18.8 +/- 6 days versus 32.3 +/- 13.7 days), a statistically significant difference (P = 0.007). CONCLUSION:NPWT reduces the granulation time of diabetic foot amputation wounds by 40%, compared with the standard wound dressing.
RCT Entities:
INTRODUCTION: Foot amputation wounds in patients with diabetes are complex and treatment is often difficult. At the moment negative pressure wound therapy (NPWT) is widely used for the treatment of several types of wounds. Nevertheless, the clinical evidence to support the application of this dressing in foot amputation wounds in patients with diabetes is scarce. The aim of this study was to evaluate the efficacy of NPWT compared with standard wound dressing to treat diabetic foot amputation wounds. PATIENTS AND METHOD: Randomised controlled trial. Diabeticpatients aged 18 years or older with a foot amputation wound were assigned to treatment with NPWT (A group) or standard wound dressing (B group). Primary efficacy end point was time in reaching 90% of wound granulation. A size of sample of 11 patients per group was used. NPWT was prepared with a polyurethane ether foam dressing, a Nelaton catheter, a transparent adhesive drape and continuous negative pressure of 100 mmHg. The wound was treated every 48-72 h and evaluated weekly. Descriptive and analytical statistics were used. RESULTS: There were 24 patients, with a mean age of 61.8 +/- 9 years (79% men), 12 in each group. The average time to reach 90% of granulation was lower in A group (18.8 +/- 6 days versus 32.3 +/- 13.7 days), a statistically significant difference (P = 0.007). CONCLUSION: NPWT reduces the granulation time of diabetic foot amputation wounds by 40%, compared with the standard wound dressing.
Authors: Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh Journal: Circulation Date: 2016-11-13 Impact factor: 29.690
Authors: Israel Gonzalez Gonzalez; Medina Andrade Luis Angel; Maria Valeria Jimenez Baez; Brenda Ruiz Flores; Maria de Los Angeles Martinez Ferretiz; Stephanny Vanestty Woolf; Israel López; Luis Sandoval-Jurado; Fany Guadalupe Pat-Espadas; Alan Alejandro Reyes Cruz; Arsenio Torres Delgado Journal: World J Surg Date: 2017-02 Impact factor: 3.352
Authors: Zhenmi Liu; Jo C Dumville; Robert J Hinchliffe; Nicky Cullum; Fran Game; Nikki Stubbs; Michael Sweeting; Frank Peinemann Journal: Cochrane Database Syst Rev Date: 2018-10-17
Authors: Carmen M Valenzuela-Silva; Ángela D Tuero-Iglesias; Elizeth García-Iglesias; Odalys González-Díaz; Amaurys Del Río-Martín; Isis Belkis Yera Alos; José I Fernández-Montequín; Pedro A López-Saura Journal: Diabetes Care Date: 2012-09-10 Impact factor: 19.112